Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9517 |
High Similarity |
NPD1512 |
Approved |
0.9463 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9379 |
High Similarity |
NPD1511 |
Approved |
0.9315 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9205 |
High Similarity |
NPD2801 |
Approved |
0.9139 |
High Similarity |
NPD1934 |
Approved |
0.8961 |
High Similarity |
NPD3882 |
Suspended |
0.8924 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8924 |
High Similarity |
NPD6166 |
Phase 2 |
0.8924 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8896 |
High Similarity |
NPD3817 |
Phase 2 |
0.8675 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8662 |
High Similarity |
NPD7075 |
Discontinued |
0.865 |
High Similarity |
NPD6797 |
Phase 2 |
0.8636 |
High Similarity |
NPD4380 |
Phase 2 |
0.8598 |
High Similarity |
NPD7251 |
Discontinued |
0.859 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.858 |
High Similarity |
NPD3818 |
Discontinued |
0.8528 |
High Similarity |
NPD7054 |
Approved |
0.8526 |
High Similarity |
NPD6801 |
Discontinued |
0.8481 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8476 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8476 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8456 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8456 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8446 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8434 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8434 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8389 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8366 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8354 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8333 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8313 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8299 |
Intermediate Similarity |
NPD943 |
Approved |
0.8299 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8293 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8228 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8224 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8204 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8165 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.816 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8158 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD919 |
Approved |
0.8125 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8082 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8052 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8027 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7976 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7975 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7961 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7904 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7871 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7843 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7815 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7815 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7792 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7792 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7785 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7758 |
Intermediate Similarity |
NPD3749 |
Approved |
0.775 |
Intermediate Similarity |
NPD920 |
Approved |
0.7727 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7688 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD447 |
Suspended |
0.764 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7625 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.761 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7473 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7453 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7446 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7438 |
Intermediate Similarity |
NPD6190 |
Approved |
0.743 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7412 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7383 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7363 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7363 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7315 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7308 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7305 |
Intermediate Similarity |
NPD37 |
Approved |
0.7283 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7267 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7255 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7228 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD2654 |
Approved |
0.72 |
Intermediate Similarity |
NPD1201 |
Approved |
0.72 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD7228 |
Approved |
0.72 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7171 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7168 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7166 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7127 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7124 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7124 |
Intermediate Similarity |
NPD3267 |
Approved |
0.712 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7118 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7115 |
Intermediate Similarity |
NPD411 |
Approved |
0.7114 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7073 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD17 |
Approved |
0.7053 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7047 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7029 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.6989 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD7697 |
Approved |
0.6963
|
Remote Similarity |
NPD7696 |
Phase 3 |